Altered insulin and glucagon secretion in treated genetic hyperlipemia: A mechanism of therapy?
- 1 March 1976
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 25 (3) , 245-249
- https://doi.org/10.1016/0026-0495(76)90082-2
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Modulation of fatty acid metabolism by glucagon in man. I. Effects in normal subjectsDiabetes, 1975
- DECREASED GLUCAGON ACTIVITY: A MECHANISM FOR GENETIC AND ACQUIRED ENDOGENOUS HYPERLIPÆMIAThe Lancet, 1974
- Effect of clofibrate on arginine-stimulated glucagon and insulin secretion in manMetabolism, 1974
- Glucagon secretion and activity in the cobalt chloride-treated ratAmerican Journal of Physiology-Legacy Content, 1973
- Effect of clofibrate on arginine-induced insulin and glucagon secretionMetabolism, 1973
- Clinical evaluation of MK‐185: A new hypolipidemic drugLipids, 1972
- Hepatic lipid metabolism in experimental diabetesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1967